Weight loss drugs could help with asthma and COPD减肥药可能有助于治疗哮喘和慢性阻塞性肺病。
Researchers find that people with chronic respiratory diseases on GLP-1 medications could have less attacks.

Semaglutide could be tied to nearly 40% fewer asthma attacks, according to medical record studies. — dpa
Semaglutide-based drugs have quickly become established as treatments for obesity and diabetes, even as signs have emerged that their appetite-suppressing effect can sometimes lead to malnutrition, and even hair loss.
But in a potential welcome side effect, semaglutide – a glucagon-like peptide-1 (GLP-1) – may also provide protection against asthma, according to Imperial College London (ICL) scientists who spoke at the European Respiratory Society (ERS) Congress held on Sept 5-9 (2026) in Barcelona, Spain.
Weight-loss drugs could also help manage addiction
Nutrition matters for GLP-1 drug users
Keeping rebound weight off after stopping GLP-1 drugs
Understanding GLP-1 drugs, those popular weight-loss medications
Meat portions shrinking due to effects of weight-loss drugs
Thank you for your report!
Malaysian tech outfit Katch launches NADI to help digitalise 1,000 wellness, fitness and sports businesses in Selangor by 2027
MySihat Expo 2026 set to become Malaysia's largest healthcare, wellness, sports and lifestyle festival
Global metabolic health market presents new growth opportunities for the international health and wellness industry
根据医疗记录研究,司美格鲁肽可能与哮喘发作减少近40%有关。——德新社
司美格鲁肽类药物已迅速成为治疗肥胖症和糖尿病的常用药物,但有迹象表明,其抑制食欲的作用有时会导致营养不良,甚至脱发。
但据伦敦帝国理工学院 (ICL) 的科学家在 2026 年 9 月 5 日至 9 日于西班牙巴塞罗那举行的欧洲呼吸学会 (ERS) 大会上发表的讲话称,索玛鲁肽(一种胰高血糖素样肽-1 (GLP-1))可能带来一个令人欣喜的副作用,即它也可能对哮喘起到保护作用。
减肥药也有助于控制成瘾。
营养对GLP-1药物使用者至关重要
如何避免停用GLP-1药物后体重反弹?
了解 GLP-1 类药物,这些流行的减肥药物
减肥药的作用导致肉类摄入量减少
感谢您的报告!
马来西亚科技公司Katch推出NADI项目,旨在到2027年帮助雪兰莪州1000家健康、健身和体育企业实现数字化转型。
2026年MySihat Expo有望成为马来西亚规模最大的医疗保健、健康、体育和生活方式盛会。
全球代谢健康市场为国际健康和保健行业带来了新的增长机遇